Nauman J - Search Results

1

Pax-8 expression correlates with type II 5' deiodinase expression in thyroids from patients with Graves' disease.

Ambroziak M, Pachucki J, Chojnowski K, Wiechno W, Nauman J, Nauman A. Ambroziak M, et al. Among authors: nauman j, nauman a. Thyroid. 2003 Feb;13(2):141-8. doi: 10.1089/105072503321319440. Thyroid. 2003. PMID: 12699588 Clinical Trial.

2

Disturbed expression of type 1 and type 2 iodothyronine deiodinase as well as titf1/nkx2-1 and pax-8 transcription factor genes in papillary thyroid cancer.

Ambroziak M, Pachucki J, Stachlewska-Nasfeter E, Nauman J, Nauman A. Ambroziak M, et al. Among authors: nauman j, nauman a. Thyroid. 2005 Oct;15(10):1137-46. doi: 10.1089/thy.2005.15.1137. Thyroid. 2005. PMID: 16279847

3

Thyroid sialyltransferase mRNA level and activity are increased in Graves' disease.

Kiljański J, Ambroziak M, Pachucki J, Jazdzewski K, Wiechno W, Stachlewska E, Górnicka B, Bogdańska M, Nauman J, Bartoszewicz Z. Kiljański J, et al. Among authors: nauman j. Thyroid. 2005 Jul;15(7):645-52. doi: 10.1089/thy.2005.15.645. Thyroid. 2005. PMID: 16053379

4

Type I 5'-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma.

Pachucki J, Ambroziak M, Tanski Z, Luczak J, Nauman J, Nauman A. Pachucki J, et al. Among authors: nauman j, nauman a. J Endocrinol Invest. 2001 Apr;24(4):253-61. doi: 10.1007/BF03343855. J Endocrinol Invest. 2001. PMID: 11383912 Clinical Trial.

5

Vitamin D receptor binding to DNA is altered without the change in its expression in human renal clear cell cancer.

Madej A, Puzianowska-Kuznicka M, Tanski Z, Nauman J, Nauman A. Madej A, et al. Among authors: nauman j, nauman a. Nephron Exp Nephrol. 2003;93(4):e150-7. doi: 10.1159/000070239. Nephron Exp Nephrol. 2003. PMID: 12759576

6

Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma.

Puzianowska-Kuznicka M, Nauman A, Madej A, Tanski Z, Cheng S, Nauman J. Puzianowska-Kuznicka M, et al. Among authors: nauman j, nauman a. Cancer Lett. 2000 Jul 31;155(2):145-52. doi: 10.1016/s0304-3835(00)00416-x. Cancer Lett. 2000. PMID: 10822129

7

Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy.

Bednarczuk T, Hiromatsu Y, Seki N, Płoski R, Fukutani T, Kuryłowicz A, Jazdzewski K, Chojnowski K, Itoh K, Nauman J. Bednarczuk T, et al. Among authors: nauman j. Hum Immunol. 2004 Jun;65(6):632-9. doi: 10.1016/j.humimm.2004.02.033. Hum Immunol. 2004. PMID: 15219383

8

[LATS and infiltrating ocular changes in Graves-Basedow's disease].

Nauman J, Nauman A. Nauman J, et al. Among authors: nauman a. Pol Arch Med Wewn. 1972 Dec;49(6):597-606. Pol Arch Med Wewn. 1972. PMID: 4678590 Polish. No abstract available.

9

[LATS in Graves-Basedow disease].

Nauman J, Nauman A. Nauman J, et al. Among authors: nauman a. Pol Arch Med Wewn. 1971;46(3):315-21. Pol Arch Med Wewn. 1971. PMID: 5108058 Polish. No abstract available.

10

[LATS-the extrapituitary thyroid stimulator and its role in the etiology and pathogenesis of Graves-Basedow disease].

Nauman J, Nauman A. Nauman J, et al. Among authors: nauman a. Pol Arch Med Wewn. 1969 Oct;43(4):1427-32. Pol Arch Med Wewn. 1969. PMID: 5395131 Polish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters